Advertisement

Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation

  • Courtney L. Ramos
    Correspondence
    Corresponding author. 3811 Valley Drive, S99, San Diego, CA 92130.
    Affiliations
    Division of Allergy, Asthma and Immunology, Scripps Clinic Medical Group, San Diego, CA, USA

    Scripps Clinic Mission Valley - 7565 Mission Valley Rd, Suite 200, San Diego, CA 92108, USA
    Search for articles by this author
  • Jennifer Namazy
    Affiliations
    Division of Allergy, Asthma and Immunology, Scripps Clinic Medical Group, San Diego, CA, USA

    Scripps Clinic Mission Valley - 7565 Mission Valley Rd, Suite 200, San Diego, CA 92108, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Immunology and Allergy Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; McHugh K, Martinez RM, Alper J, editors. Advancing Maternal Health Equity and Reducing Maternal Morbidity and Mortality: Proceedings of a Workshop. Washington (DC): National Academies Press (US); 2021 Oct 28. Available from: https://www.ncbi.nlm.nih.gov/books/NBK575264/ doi: 10.17226/26307.

        • Chinn J.J.
        • Eisenberg E.
        • Artis Dickerson S.
        • et al.
        Maternal mortality in the United States: research gaps, opportunities, and priorities.
        Am J Obstet Gynecol. 2020; 223: 486-492 e6
      2. What are examples and causes of maternal morbidity and mortality?.
        (Available at:) (Accessed date May 14 2020)
        • Breton M.C.
        • Beauchesne M.F.
        • Lemiere C.
        • et al.
        Risk of perinatal mortality associated with asthma during pregnancy.
        Thorax. 2009; 64: 101-106
        • Murphy V.E.
        • Wang G.
        • Namazy J.A.
        • et al.
        The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis.
        BJOG. 2013; 120: 812-822
        • Namazy J.A.
        • Schatz M.
        Contemporary management and treatment strategies for asthma during pregnancy.
        Expert Rev Respir Med. 2021; 15: 1149-1157
        • Ambros-Rudolph C.M.
        Dermatoses of pregnancy - clues to diagnosis, fetal risk and therapy.
        Ann Dermatol. 2011; 23: 265-275
        • Mawhirt S.L.
        • Fonacier L.
        Atopic Dermatitis and allergic Contact Dermatitis in pregnancy.
        Asthma, allergic and immunologic diseases during pregnancy. 2018;
        • Pali-Scholl I.
        • Namazy J.
        • Jensen-Jarolim E.
        Allergic diseases and asthma in pregnancy, a secondary publication.
        World Allergy Organ J. 2017; 10: 10
      3. Carroll MP, Bulkhi AA, Lockey RF. Rhinitis and Sinusitis. In: Namazy J, Schatz M, editors. Asthma, Allergic and Immunologic Diseases During Pregnancy. Springer, Cham. 2019. https://doi.org/10.1007/978-3-030-03395-8_5.

        • Brauer D.L.
        • Woessner K.M.
        Non-pharmacologic aspects of management: asthma and allergic and immunologic diseases during pregnancy a guide to managemenî asthma.
        Allergic and Immunologic Diseases During Pregnancy. 2018;
        • Kwon H.L.
        • Triche E.W.
        • Belanger K.
        • et al.
        The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms.
        Immunol Allergy Clin North Am. 2006; 26: 29-62
        • Weatherhead S.
        • Robson S.C.
        • Reynolds N.J.
        Eczema in pregnancy.
        BMJ. 2007; 335: 152-154
        • Ambros-Rudolph C.M.
        • Mullegger R.R.
        • Vaughan-Jones S.A.
        • et al.
        The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients.
        J Am Acad Dermatol. 2006; 54: 395-404
        • Martin J.A.
        • Hamilton B.E.
        • Osterman M.
        Births in the United States, 2020.
        NCHS Data Brief. 2021; : 1-8
      4. Early Pregnancy Loss.
        (2022 January 2022; November 2021:Available at:) (Accessed January 1, 2022)
        • Wang W.
        • Sung N.
        • Gilman-Sachs A.
        • et al.
        T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells.
        Front Immunol. 2020; 11: 2025
        • Kircher S.
        • Schatz M.
        • Long L.
        Variables affecting asthma course during pregnancy.
        Ann Allergy Asthma Immunol. 2002; 89: 463-466
        • Ali Z.
        • Nilas L.
        • Ulrik C.S.
        Postpartum airway responsiveness and exacerbation of asthma during pregnancy - a pilot study.
        J Asthma Allergy. 2017; 10: 261-267
        • Bain E.
        • Pierides K.L.
        • Clifton V.L.
        • et al.
        Interventions for managing asthma in pregnancy.
        Cochrane Database Syst Rev. 2014; : CD010660
        • Yoo E.J.
        • Most J.F.
        • Lee N.L.
        • et al.
        Improving Asthma Symptoms Among Inner-City Women During Pregnancy: A Prospective Cohort Intervention.
        J Allergy Clin Immunol Pract. 2021; 9: 3672-3678
        • Namazy J.A.
        Asthma: management. Asthma, allergic and immunologic diseases during pregnancy.
        2018
      5. Division of Pediatric and Maternal Health - Clinical Trials in Pregnant Women.
        (Available at:) (Accessed date January 10 2022)
        • Wangberg H.
        • Namazy J.
        Predicting Who Will Stop Medications During Pregnancy: A Complex Issue.
        J Allergy Clin Immunol Pract. 2021; 9: 1253-1254
        • Suh H.Y.
        • Peck C.C.
        • Yu K.S.
        • et al.
        Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013.
        Drug Des Devel Ther. 2016; 10: 4005-4016
      6. Birth Defects are Common, Costly, and Critical.
        (Available at:) (Accessed date December 5 2019)
        • World Health Organization
        Congenital anomalies.
        (Available at:) (Accessed January 1, 2022)
        • Namazy J.
        • Cabana M.D.
        • Scheuerle A.E.
        • et al.
        The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy.
        J Allergy Clin Immunol. 2015; 135: 407-412
        • Scheuerle A.
        • Tilson H.
        Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry.
        Pharmacoepidemiol Drug Saf. 2002; 11: 465-475
        • Moro P.
        • Baumblatt J.
        • Lewis P.
        • et al.
        Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System.
        Drug Saf. 2017; 40: 145-152
        • Chambers C.
        Safety of Asthma and Allergy medications during pregnancy. Asthma.
        Allergic and Immunologic Diseases During Pregnancy, 2018
      7. MotherToBaby.
        ([internet]; Available at:) (Accessed January 1, 2022)
      8. List of Pregnancy Exposure Registries.
        (Available from:) (Accessed date January 9 2022)
        • Genentech
        • Novartis
        Omalizumab (Xolair) [package insert]. U.S. Food and Drug Administration website.
        (Available at:) (Accessed January 1, 2022)
        • Namazy J.A.
        • Blais L.
        • Andrews E.B.
        • et al.
        Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.
        J Allergy Clin Immunol. 2020; 145: 528-536 e1
      9. GSK. Mepolizumab (Nucala) [package insert]. U.S. Food and Drug Administration website.
        (Available at:) (Accessed January 1, 2022)
        • Ozden G.
        • Pinar Deniz P.
        May mepolizumab used in asthma correct subfertility?.
        Ann Med. 2021; 53: 456-458
      10. TEVA. Reslizumab (Cinqair) [package insert]. U.S. Food and Drug Administration website.
        (Available at:) (Accessed January 1, 2022)
      11. AstraZeneca. Benralizumab (Fasenra) [package insert]. U.S. Food and Drug Administration website.
        (Available at:) (Accessed January 1, 2022)
        • Manetz S.
        • Maric I.
        • Brown T.
        • et al.
        Successful pregnancy in the setting of eosinophil depletion by benralizumab.
        J Allergy Clin Immunol Pract. 2021; 9: 1405-1407 e3
      12. Sanofi and Regeneron Pharmaceuticals. Dupilumab (Dupixent) [package insert]. U.S. Food and Drug Administration website.
        (Available at:) (Accessed date January 13, 2022)
        • Bosma A.L.
        • Gerbens L.A.A.
        • Middelkamp-Hup M.A.
        • et al.
        Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series.
        Clin Exp Dermatol. 2021; 46: 1089-1092
        • Mian M.
        • Dunlap R.
        • Simpson E.
        Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report.
        JAAD Case Rep. 2020; 6: 1051-1052
        • Gracia-Darder I.
        • Pons De Ves J.
        • Reyero Cortina M.
        • et al.
        Patient with atopic dermatitis, hyper IgE syndrome and ulcerative colitis, treated successfully with dupilumab during pregnancy.
        Dermatol Ther. 2021; : e15237
        • Costley M.
        • Murphy B.
        Successful treatment of a pregnant mother with dupilumab therapy for severe atopic dermatitis throughout pregnancy.
        Clin Exp Dermatol. 2021;
        • Lobo Y.
        • Lee R.C.
        • Spelman L.
        Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature.
        Case Rep Dermatol. 2021; 13: 248-256
        • Khamisy-Farah R.
        • Damiani G.
        • Kong J.D.
        • et al.
        Safety profile of Dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBase).
        Eur Rev Med Pharmacol Sci. 2021; 25: 5448-5451
      13. AstraZeneca. Tezepelumab (Tezspire) [package insert]. U.S. Food Drug Administration website.
        (Available at:) (Accessed January 1, 2022)
      14. Vaccines and Medications in Pregnancy Surveillance System (VAMPSS).
        (Available at:) (Accessed date February 23 2022)